Injectable Sodium Chloride Recalled for Potential Container Leaks Compromising Sterility
ICU Medical is recalling 137,120 bags of 0.9% Sodium Chloride Injection because bags may leak and potentially compromise sterility. The affected lot (5829936) was distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a FDA Class II recall where bags may leak and compromise sterility, but no illnesses or injuries have been reported. Per the rubric, theoretical hazards without reported harm cannot exceed severity 3 (High).
Plain-English summary
ICU Medical Inc. is recalling 137,120 bags of 0.9% Sodium Chloride Injection, USP, 100 mL flexible container bags. The affected lot is 5829936, with expiration date March 31, 2024.
The recall is due to lack of assurance of sterility. Bags have the potential to leak in the flexible containers, which may compromise sterility of the injectable solution.
The recalled bags were distributed nationwide in the USA.
The recalled product
- Product
- SODIUM CHLORIDE (SODIUM CHLORIDE)
- Brand
- SODIUM CHLORIDE
- Manufacturer
- ICU Medical Inc
- Category
- Drug — Intravenous Solution
- Hazard
- product-leakage
- sterility-compromise
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 5829936
- Exp. MAR 31 2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SODIUM CHLORIDE
- SevereFDA Class I Recall: B. Braun Sodium Chloride Injection for Particulate Matter
FDA (Drugs) · 2024-08-28
- ModerateIntravenous Sodium Chloride Injection Recalled for Incomplete Labeling and Warnings
FDA (Drugs) · 2023-08-16
- HighSodium Chloride Injection Bags Recalled for Potential Leakage and Sterility Risk
FDA (Drugs) · 2023-07-19
- HighSodium Chloride Injection Recalled Due to Storage Temperature Exposure Risk
FDA (Drugs) · 2023-06-07
- HighSodium Chloride Injection Recalled for Incomplete Seal and Potential Leakage
FDA (Drugs) · 2023-03-01
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01